anti-leukocyte immunoglobulin like receptor B2 antibody (Kyinno)

N/A

Report date: 2025/06/11 11:06:46

Base Information

Drug Nameanti-leukocyte immunoglobulin like receptor B2 antibody (Kyinno)
Drug Alias Nameanti LLIRB-2 antibody (Kyinno)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsLeukocyte immunoglobulin-like receptor subfamily B member 2 inhibitors +[4] 
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKYinno Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A